BioLargo, Inc. was recently featured in MicroCap Review's Summer/Fall 2014 print and online issues. BioLargo is featured on page 30 in an article titled, 'Is BioLargo's 'AOS Filter' the World's Most Valuable Technology?' where the author discusses the company's Advanced Oxidation System (AOS) Filter solution and its multiple applications in the $360 billion water industry.
For more information on the article, please visit www.biolargo.blogspot.com.
The full publication can be accessed at www.MicroCapReview.com.
About BioLargo, Inc.
BioLargo, Inc. (OTCQB: BLGO) makes life better by delivering technology-based products that help solve some of the world's most important problems that threaten water, food, agriculture, healthcare and energy. More information can be found about the company and its subsidiaries at www.BioLargo.com. The subsidiary BioLargo Water, Inc. (www.BioLargoWater.com) showcases the Advanced Oxidation Systems, including its AOS Filter, a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. BioLargo also owns a 50% interest in the Isan System, which was honored with a 'Top 50 Water Company for the 21st Century' award by the Artemis Project. The subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, and consumer markets, including the Nature's Best Solution® and Deodorall® brands. (www.OdorNoMore.com). The subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com), focuses on advanced wound care management and is preparing to make FDA 510(k) applications in 2014.